StockData
Cingulate Inc. logo

Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.72+0.97 (+25.87%)

Close on Nov 17, 2026Market cap $68.64MP/E –Yield –

Cingulate shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Cingulate's shares outstanding was 13M at Jun 30, 2026. For fiscal 2025 it was 5M, up 231.5% from the year before. The highest annual figure on record is 5M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255M+231.5%
FY2024Dec 31, 20242M+1921.3%
FY2023Dec 31, 20230M-87.5%
FY2022Dec 31, 20221M+51.7%
FY2021Dec 31, 20210M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202613M+200.4%
Q1 FY2026Mar 31, 202610M+168.1%
Q4 FY2025Dec 31, 20257M+1534.0%
Q3 FY2025Sep 30, 20255M+4310.6%
Q2 FY2025Jun 30, 20254M+5229.5%
Q1 FY2025Mar 31, 20254M+274.2%
Q1 FY2024Mar 31, 20240M-27.1%
Q4 FY2023Dec 31, 20230M-79.2%
Q3 FY2023Sep 30, 20230M-86.4%
Q2 FY2023Jun 30, 20231M+60.9%
Q1 FY2023Mar 31, 20231M-6.7%
Q4 FY2022Dec 31, 20221M–
Q3 FY2022Sep 30, 20221M–
Q2 FY2022Jun 30, 20221M–
Q1 FY2022Mar 31, 20221M–

More Cingulate figures

See a number that looks wrong?